We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Sponsor content
839 result(s) found, displaying 351 to 360
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BORTEZOM bortezomib 3.5 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AKM DIMETHYL FUMARATE dimethyl fumarate 120 mg delayed release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FURATEC dimethyl fumarate 240 mg delayed release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FURATEC dimethyl fumarate 120 mg delayed release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR DIMETHYL FUMARATE dimethyl fumarate 240 mg delayed release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for AKM DIMETHYL FUMARATE dimethyl fumarate 240 mg delayed release capsule blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR DIMETHYL FUMARATE dimethyl fumarate 120 mg delayed release capsule blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2023
-
Prescription medicine registrationActive ingredients: Ezetimibe, Rosuvastatin calcium.